Rapid Micro Biosystems (RPID) Research & Development (2020 - 2026)

Rapid Micro Biosystems has disclosed Research & Development across 7 years of filings, most recently posting $3.4 million for Q2 2026.

• In Q2 2026, Research & Development rose 6.38% year-over-year to $3.4 million; the TTM figure through Jun 2026 stood at $13.6 million (down 1.86% YoY), while the FY2025 annual figure was $13.6 million, down 6.81% from the prior year.
• Research & Development came in at $3.4 million for Q2 2026 at Rapid Micro Biosystems, roughly flat from $3.4 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $4.1 million in Q4 2022 to a low of $3.2 million in Q4 2023.
• Average Research & Development over 5 years is $3.5 million, with a median of $3.5 million recorded in 2022.
• Year-over-year, Research & Development surged 54.95% in 2022 and decreased 23.35% in 2023.
• Over 5 years, Research & Development stood at $4.1 million in 2022, then declined by 23.35% to $3.2 million in 2023, then rose by 7.62% to $3.4 million in 2024, then decreased by 5.35% to $3.2 million in 2025, then gained by 6.71% to $3.4 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $3.4 million in Q2 2026, $3.4 million in Q1 2026, and $3.2 million in Q4 2025.